Combination of the First-in-Class Imipridone ONC201 and Standard Anticancer Therapies as a Rational Approach for Therapeutic Benefit
The development of drugs for cancer treatment faces critical challenges due to the heterogeneity in cancers, metastatic nature of the disease, lack of efficacy, toxicity, and drug resistance. This makes it quite important to understand the complexities of cancer as well as the limitations of druggab...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2025-09-01
|
| coleção: | Current Issues in Molecular Biology |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/1467-3045/47/9/775 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|